Samrat Pharmachem Ltd
BSE:530125
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (1.6), the stock would be worth ₹372.94 (77% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.9 | ₹211.1 |
0%
|
| 3-Year Average | 1.6 | ₹372.94 |
+77%
|
| 5-Year Average | 1.8 | ₹411.73 |
+95%
|
| Industry Average | 2.2 | ₹520.31 |
+146%
|
| Country Average | 2.3 | ₹524.6 |
+149%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Samrat Pharmachem Ltd
BSE:530125
|
652.2m INR | 0.9 | -38.9 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.2T JPY | 3.1 | 27.8 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
78.8B USD | 3.8 | 30.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
73.2B USD | 3.6 | 35.3 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.6 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280.3B CNY | 1.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.7B CHF | 2.9 | 24 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 6.6 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 10.8 | 60.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24B USD | 1.8 | 15.2 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.6 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.3 |
| Median | 2.3 |
| 70th Percentile | 4.2 |
| Max | 4 185.7 |
Other Multiples
Samrat Pharmachem Ltd
Glance View
Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. The company serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The firm exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.
